Related Experiment Video
Updated: Aug 14, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mdm2-mediated pRB downregulation is involved in carcinogenesis in a p53-independent manner
Seiichi Miwa1, Chiharu Uchida, Kyoko Kitagawa
1Department of Biochemistry 1, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka 431-3192, Japan.
Abstract:
Mdm2 promotes ubiquitination of the tumor suppressor p53 and can function as an oncogene by largely downregulating p53. Although a p53-independent role of Mdm2 has been reported, the underlying mechanism remains unclear. In the present study, we indicated that Mdm2 is involved in p53-independent carcinogenesis via downregulation of pRB. Expression of pRB showed an apparent inverse correlation with Mdm2 expression in 30 patients with non-small cell lung cancer. There were some cases with the p53 mutations in which a high level of Mdm2 and a low level of pRB were expressed. Mdm2 promoted ubiquitination of pRB in cells without wild-type p53. Furthermore, pRB-mediated G1 arrest in a p53-deficient cell line, SRB1, was significantly enhanced by a mutant Mdm2 that lacks pRB ubiquitination activity. Soft-agar colony formation activity of p53-knockout MEF was increased by wild-type Mdm2 but not mutant Mdm2. These findings suggest that overexpression of Mdm2 can perturb a RB pathway regardless of the p53 gene status, promoting carcinogenesis.
Insights
Mdm2 drives cancer independently of p53 by downregulating pRB. This protein Mdm2 targets pRB for degradation, promoting cell proliferation and tumor growth even when p53 is absent or mutated.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Mdm2 is known to promote tumor development by downregulating the tumor suppressor p53.
- The p53-independent functions of Mdm2 in carcinogenesis are not well understood.
Purpose of the Study:
- To investigate the role of Mdm2 in p53-independent carcinogenesis.
- To elucidate the mechanism by which Mdm2 promotes cancer development independent of p53.
Main Methods:
- Analyzing Mdm2 and pRB expression in non-small cell lung cancer patient samples.
- Investigating Mdm2-mediated ubiquitination of pRB in p53-deficient cells.
- Assessing the impact of Mdm2 on pRB-mediated cell cycle arrest.
- Evaluating the effect of Mdm2 on anchorage-independent growth in p53-knockout cells.
Main Results:
- Mdm2 expression inversely correlated with pRB expression in non-small cell lung cancer patients.
- Mdm2 promoted pRB ubiquitination and degradation in a p53-independent manner.
- Mdm2 overexpression enhanced pRB-mediated G1 arrest and promoted soft-agar colony formation in p53-deficient cells.
Conclusions:
- Mdm2 overexpression can promote carcinogenesis by disrupting the pRB pathway, irrespective of p53 status.
- Mdm2 represents a potential therapeutic target for cancers with altered p53 or pRB pathways.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Master Transcription Regulators
